Jobs in Cambridge

Medical Director Clinical Development- Respiratory

Lead clinical development for respiratory assets within GSK’s Respiratory, Immunology & Inflammation Research Unit, driving translational and clinical strategies from early to late stages. Provide medical oversight, design studies, and collaborate across functions to deliver innovative medicines addressing unmet patient needs in respiratory disease.

GSK Stevenage, United Kingdom

Medical Director, Oncology Clinical Development - Hematology

This role involves leading medical oversight in oncology clinical development, focusing on hematology and clonal myeloid disorders. The Medical Director will guide study design, ensure patient safety, interpret clinical data, and collaborate with cross-functional teams and external experts. It is a physician-led position embedded in clinical strategy with a strong emphasis on real-world impact and regulatory engagement.

GSK Stevenage, United Kingdom PLN 455,250 – PLN 758,750 pa

Senior Director, Portfolio Integration Lead - Hematology

Leads cross-programme scientific strategy and integration across GSK’s hematology oncology portfolio, ensuring alignment in clinical development, biomarker strategies, and innovative trial design. Acts as a senior scientific partner to Clinical Development Leads and drives data-driven decision-making using emerging technologies like AI. Operates at the portfolio level to shape disease-area strategy and support regulatory and governance engagement.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

Lead scientific and strategic integration across GSK's hematology oncology portfolio, ensuring alignment of clinical development programmes, biomarker strategies, and innovative trial designs. Drive cross-asset coordination and decision-making at the disease level, leveraging deep oncology expertise and emerging technologies like AI. Engage with internal stakeholders and external experts to shape portfolio direction and regulatory strategy.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

This role leads cross-programme scientific strategy and integration across GSK’s hematology oncology portfolio, ensuring alignment in disease biology, biomarker development, and clinical trial innovation. The individual will drive portfolio-level decision-making, shape clinical development approaches using emerging technologies like AI, and engage with external experts and regulatory bodies. It is a senior individual contributor position focused on strategic coherence across multiple assets rather than direct management of a single programme.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Executive Medical Director, Clinical Development Lead - Oncology

Leads clinical development strategy for oncology assets, defining the scientific narrative and benefit-risk framework across the lifecycle. Acts as the primary clinical authority, shaping strategic direction and governance decisions while leveraging AI and advanced analytics to accelerate development. Represents Clinical Development in internal and external forums, including regulatory interactions and alliance partnerships.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Executive Medical Director, Clinical Development Lead - Oncology

This role leads the clinical development strategy for oncology assets at GSK, defining the scientific narrative, benefit-risk framework, and decision-making roadmap across the asset lifecycle. The Executive Medical Director serves as the primary clinical authority within the Medicine Development Team, shaping strategic governance, regulatory engagement, and evidence generation. They drive innovation through AI-enabled insights and advanced analytics while mentoring clinical talent and ensuring alignment across regulatory, commercial, and medical functions.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Director, Clinical Science – Oncology Clinical Development

Provides scientific leadership in oncology clinical development, contributing to study design, data interpretation, and regulatory documentation within a defined clinical programme. Works closely with cross-functional teams to ensure scientific rigor and alignment with clinical strategy, while supporting the execution of clinical studies from early to late stages. Focuses on generating robust clinical insights to advance cancer therapies with high unmet need.

GSK United States £189,750 – £316,250 pa

Hybrid Permanent

Director, Clinical Science – Oncology Clinical Development

Lead scientific strategy for oncology clinical studies, contributing to protocol design, data interpretation, and regulatory documentation within a global matrix team. Focus on advancing cancer therapies with high unmet need through rigorous clinical development and cross-functional collaboration. Emphasis on scientific excellence, real-world impact, and innovation in patient-focused drug development.

GSK PLN 472,500 – PLN 787,500 pa

Hybrid Permanent

Director, Clinical Science – Oncology Clinical Development

Lead scientific strategy for oncology clinical studies, contributing to protocol design, data interpretation, and regulatory deliverables within a global pharmaceutical environment. Collaborate across functions to ensure scientific rigor and alignment with clinical development goals, while engaging with external experts and supporting regulatory submissions. The role emphasizes innovation, data-driven decision-making, and continuous improvement in clinical development processes.

GSK £189,750 – £316,250 pa

Hybrid Permanent

Director, Clinical Science – Oncology Clinical Development

Lead scientific contributions to oncology clinical studies, focusing on protocol design, data interpretation, and regulatory documentation within a global matrix team. Provide expert input to clinical development plans and collaborate with cross-functional teams to advance cancer therapies. Engage with external experts and support regulatory submissions to drive patient impact.

GSK PLN 472,500 – PLN 787,500 pa

Hybrid Permanent

Director, Clinical Science – Oncology Clinical Development

Leads scientific components of oncology clinical studies, contributing to protocol design, data interpretation, and regulatory documentation within a defined clinical programme. Works closely with cross-functional teams to ensure scientific rigor and alignment with development goals. Focuses on generating robust clinical insights to advance cancer therapies in high unmet need areas.

GSK US$189,750 – US$316,250 pa

Hybrid Permanent

Director, Clinical Science – Oncology Clinical Development

Provides scientific leadership in oncology clinical development, contributing to study design, data interpretation, and regulatory deliverables within a defined clinical programme. Works closely with cross-functional teams and external experts to ensure scientific rigor and data integrity. Focuses on advancing cancer therapies with high unmet need through robust clinical science and collaboration.

GSK US$189,750 – US$316,250 pa

Hybrid Permanent

Medical Director, Oncology Clinical Development - Hematology

This role involves providing medical leadership in oncology clinical development, with responsibilities spanning study design, medical monitoring, safety oversight, and data interpretation. The Medical Director will integrate physician-level insights into clinical trials, collaborate with cross-functional teams and external experts, and contribute to regulatory submissions and scientific communications. The position emphasizes patient-centered decision-making and real-world impact in cancer treatment innovation.

GSK £222,750 – £371,250 pa

Hybrid Permanent

Sr Director and Team Lead, Regulatory Labelling Strategy and Development, Oncology

Leads a global team responsible for developing and managing regulatory labelling strategies for oncology products across the drug development lifecycle. Ensures compliance with global regulations, collaborates with cross-functional stakeholders in R&D, safety, and commercial teams, and engages with regulatory authorities to shape innovative, patient-focused labelling. Plays a strategic role in governance and policy development within GSK’s oncology portfolio.

GSK £221,925 – £369,875 pa